2024 Medicare Advantage Prescription Drug Price Information | ||||||
HumanaChoice R0865-003 (Regional PPO) (R0865-003-0) Benefits & Contact Info Insulin on a Medicare Part D plan's formulary will have a monthly copay of $35 or less. | ||||||
Click on a letter below to view the HumanaChoice R0865-003 (Regional PPO) Formulary A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9 | ||||||
ZUBSOLV 2.9-0.71 MG TABLET SL | ||||||
Plan’s average negotiated retail drug price in in Statewide, KY: CMS MA Region 13, includes: IN KY | $291.73* 30-Day Supply $875.20* 90-Day Supply | |||||
Formulary (Drug List) drug tier: | Tier #2: Generic This Tier has No Deductible. | |||||
Does this plan offer any Gap coverage? | Yes | |||||
Does this drug have Gap coverage? | Yes, this drug has coverage in the gap and brand-name drugs receive an additional, partial donut hole discount. | |||||
Drug Usage Management Restrictions: | Quantity Limit:90/30Days | |||||
Formulary (Drug List) Tier Cost-Sharing Details | ||||||
Insulin on a Medicare Part D plan's formulary will have a monthly copay of $35 or less. | ||||||
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
|||||
Preferred Pharmacy | Standard Pharmacy | Mail- Order** | Preferred Pharmacy | Standard Pharmacy | Mail- Order** | |
Initial $245 Deductible Cost Sharing: | ||||||
$5.00 | $5.00 | $5.00 | $15.00 | $15.00 | $0.00 | |
Initial Coverage Phase Cost-Sharing: | ||||||
$5.00 | $5.00 | $5.00 | $15.00 | $15.00 | $0.00 | |
Coverage Gap Phase Cost-Sharing: | ||||||
$5.00 | $5.00 | $5.00 | $15.00 | $15.00 | $0.00 | |
Plus Additional Donut Hole Discount (Generics 75%): | ||||||
25% | 25% | 25% | 25% | 25% | 25% | |
Plus Additional Donut Hole Discount (Brand 75%): | ||||||
25% | 25% | 25% | 25% | 25% | 25% | |
Catastrophic Coverage Phase Cost-Sharing (all Formulary Drugs): | ||||||
$0 | $0 | $0 | $0 | $0 | $0 | |
Your Estimated Cost for Purchases During Each Coverage Phase | ||||||
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
|||||
Preferred Pharmacy | Standard Pharmacy | Mail- Order** | Preferred Pharmacy | Standard Pharmacy | Mail- Order** | |
Your Estimated Cost in Deductible Phase: | ||||||
$10.00 | $10.00 | $10.00 | $30.00 | $30.00 | $0.00 | |
Your Estimated Cost Initial Coverage Phase: | ||||||
$5.00 | $5.00 | $5.00 | $15.00 | $15.00 | $0.00 | |
Your Estimated Cost in Gap if Drug is Generic (75% discount): | ||||||
Your Estimated Cost in Gap if Drug is Brand-Name (75% discount): | ||||||
$72.93 | $72.93 | $72.93 | $218.80 | $218.80 | $218.80 | |
Your Estimated Cost in Catastrophic Coverage (all Formulary Drugs): | ||||||
$0 | $0 | $0 | $0 | $0 | $0 | |
Tier Cost-Sharing Details and Your Costs with Explanations | ||||||
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
|||||
Preferred Pharmacy | Standard Pharmacy | Mail- Order** | Preferred Pharmacy | Standard Pharmacy | Mail- Order** | |
--- If you purchase during the Initial Deductible Phase --- | ||||||
Initial $245 Deductible Cost Sharing: | ||||||
$5.00 | $5.00 | $5.00 | $15.00 | $15.00 | $0.00 | |
Your Estimated Cost in Deductible Phase: | ||||||
$10.00 | $10.00 | $10.00 | $30.00 | $30.00 | $0.00 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
For a purchase of this drug made during the initial deductible phase, you cross over into other phases of your plan’s coverage (straddle claim). So you pay 100% of the drug cost up to your deductible of $245 and the remaining amount ($291.73-$245) (price - deductible) falls into your initial coverage phase (ICP). For the ICP portion of your coverage, your cost-sharing would be an additional $5.00, a flat co-pay up to your coverage limit of . Your estimated cost for a purchase made during the deductible phase would be $10.00 or $5.00 from deductible phase + $5.00 from initial coverage phase. | ||||||
--- If you purchase during the Initial Coverage Phase --- | ||||||
Initial Coverage Phase Cost-Sharing: | ||||||
$5.00 | $5.00 | $5.00 | $15.00 | $15.00 | $0.00 | |
Your Estimated Cost Initial Coverage Phase: | ||||||
$5.00 | $5.00 | $5.00 | $15.00 | $15.00 | $0.00 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
The cost-sharing for purchases made during the initial coverage phase (ICP) would be a flat fee of $5.00. | ||||||
--- If you purchase during the Coverage Gap Phase (Donut Hole) --- | ||||||
Coverage Gap Phase Cost-Sharing: | ||||||
$5.00 | $5.00 | $5.00 | $15.00 | $15.00 | $0.00 | |
Your Estimated Cost in Gap if Drug is Generic (75% discount): | ||||||
Your Estimated Cost in Gap if Drug is Brand-Name (75% discount): | ||||||
$72.93 | $72.93 | $72.93 | $218.80 | $218.80 | $218.80 | |
--- If you purchase during the Catastrophic Coverage Phase --- | ||||||
Catastrophic Coverage Phase Cost-Sharing (all Formulary Drugs): | ||||||
$0 | $0 | $0 | $0 | $0 | $0 | |
Your Estimated Cost in Catastrophic Coverage (all Formulary Drugs): | ||||||
$0 | $0 | $0 | $0 | $0 | $0 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
Beginning with plan year 2024, the Inflation Reduction Act (IRA) of 2022 eliminates beneficiary cost-sharing once your TrOOP reaches $8,000 -- the established maximum cap on out-of-pocket spending for Part D formulary drugs (RxMOOP). | ||||||
HumanaChoice R0865-003 (Regional PPO) Average Negotiated Retail Drug Price History | ||||||
30-Day Supply | 90 Day Supply | |||||
June, 2024: | $291.73 | $875.20 | ||||
March, 2024: | $291.73 | $875.20 | ||||
January, 2024: | $280.70 | $842.11 | ||||
September, 2023: | $320.62 | $961.88 | ||||
June, 2023: | $320.70 | $962.10 | ||||
March, 2023: | $320.40 | $961.20 | ||||
January, 2023: | $308.10 | $924.30 | ||||
September, 2022: | $308.10 | $924.30 | ||||
June, 2022: | $308.10 | $924.30 | ||||
March, 2022: | $308.10 | $924.30 | ||||
January, 2022: | $299.10 | $897.30 | ||||
September, 2021: | $291.00 | $873.00 | ||||
June, 2021: | $291.00 | $873.00 | ||||
March, 2021: | $291.00 | $873.00 | ||||
January, 2021: | $282.00 | $846.00 | ||||
September, 2020: | $280.20 | $840.60 | ||||
June, 2020: | $280.20 | $840.60 | ||||
March, 2020: | $280.20 | $840.60 | ||||
January, 2020: | $272.10 | $816.30 | ||||
September, 2019: | $272.57 | $816.62 | ||||
June, 2019: | $272.57 | $816.62 | ||||
March, 2019: | $272.57 | $816.62 | ||||
January, 2019: | $262.11 | $785.25 | ||||
September, 2018: | $248.87 | $744.50 | ||||
June, 2018: | $248.87 | $744.50 | ||||
March, 2018: | $248.80 | $744.28 | ||||
January, 2018: | $235.36 | $703.97 | ||||
September, 2017: | n/a | n/a | ||||
June, 2017: | n/a | n/a | ||||
March, 2017: | n/a | n/a | ||||
January, 2017: | n/a | n/a | ||||
September, 2016: | ||||||
June, 2016: | ||||||
April, 2016: | ||||||
January, 2016: | ||||||
September, 2015: | ||||||
June, 2015: | ||||||
April, 2015: | ||||||
January, 2015: | ||||||
September, 2014: | ||||||
June, 2014: | ||||||
March, 2014: | ||||||
January, 2014: | ||||||
October, 2013: | ||||||
January, 2013: | -- | |||||
April, 2012: | -- | |||||
September, 2010: | -- | |||||
Notes:
*The Medicare drug plan’s average negotiated retail drug price is based on several variables: the medication, the quantity of your prescription, the specific Medicare Part D plan, and the pharmacies in the plan’s service area. In this case, the average of the ZUBSOLV 2.9-0.71 MG TABLET SL prices that the HumanaChoice R0865-003 (Regional PPO) has negotiated with each of the retail pharmacies in the plan’s service area (in Statewide, KY: CMS MA Region 13, includes: IN KY). In other words, when you use the HumanaChoice R0865-003 (Regional PPO) to purchase ZUBSOLV 2.9-0.71 MG TABLET SL, you may pay slightly more or slightly less than the figures shown in the table above depending on the pharmacy where you fill your prescription and the quantity of your prescription. The example average retail prices used above are based on a quantity of 30 for the 30-day supply and a quantity of 90 for the 90-day supply. **The mail-order cost-sharing is the plan’s "preferred" mail-order cost-sharing. |
||||||
Return to the HumanaChoice R0865-003 (Regional PPO) 2024 Formulary Browser by choosing a letter below: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9 |